InsidersTradesSigma
NextCell Pharma AB: directors' dealings · Finland · FIN-FSA
FI:nextcell-pharma-abSE0022240800FI·FIN-FSAMcap 118M€Healthcare
Explore the full directors' dealings record of NextCell Pharma AB, a listed issuer based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, NextCell Pharma AB has recorded 3 reports. Market capitalisation: €118.3m. The latest transaction was reported on 2 June 2025 (Other). Among the most active insiders: Patrik Fagerholm. The full history is openly available.
3
Insider Decl.
0
Thresholds
€821
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.06 €
Analyst consensus
1 analysts3.50 €Target 3.50 €(+230%)3.50 €
Income statement
Revenue10.0 M€
Gross profit1.6 M€16% margin
Net income−39.4 M€-395.2% margin
Valuation
P/Book2.3x
Beta0.65
Balance sheet & cash
Market cap118.3 M€
Free Cash Flow−37.9 M€
Profitability & ownership
% insiders30.9%
% institutions6.6%
Last declaration on 2 June 2025
Declarations3 total
Executives●Other42FIN-FSA
€27,463298,440 shares@ €0.0920.023% mcap96.7% of flow
Aktie
FI:A003P179-2·
Executives●Other31FIN-FSA
€1211,320 shares@ €0.0920.0001% mcap0.4% of flow
Aktie
FI:A003P178-2·
Executives●Purchase20FIN-FSA
€821100,000 shares@ €0.00820.0007% mcap2.9% of flow
Teckningsoption
FI:A003N606-1·
Ideal exit: 23 Jan 2026 (T+270)
3 of 3 declarations